explore -WSS

explore

author：hotspot 2025-10-03 00:39:18 - browse：17847

3D DNA on a sheet of paper listing nucleic acid sequences — coverage from STAT — Adobe

Ultima Genomics, an upstart some observers have called a “dark horse” in the world of DNA sequencing, will soon launch a line of high-power instruments that can read a human genome for as little as $100, the company’s leadership told STAT.

The sequencer, dubbed the UG 100, is a $1.5 million machine that can read up to 20,000 human genomes a year. The reagents required to operate the instrument cost as little as $1 per billion sequenced DNA bases; that translates to $100 per genome assuming each base in the 3-gigabase human genome is read 33 times, a common industry standard. The company plans to officially launch the product at this year’s Advances in Genome Biology and Technology meeting, which kicks off in Orlando, Fla., on Feb. 5.

The product’s cost and maximum output put it roughly in the same range as a line of high-throughput instruments launched in September 2022 by Illumina, which controls an estimated 80% of the sequencing market. But Ultima is hoping it can chip into the sequencing giant’s market share among genome centers, large clinical labs, and others with an appetite for reams of genetic data by offering lower operating costs and greater flexibility.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： NVIDIA and Google execs on the future of AI and drug discovery

WSS

Helping hospitals and community health centers plan for resilience

Physician executives need more than on

Readout LOUD podcast: Live from STAT Breakthrough Summit West

Phenylephrine and the overlooked value of the placebo effect

What to expect at HLTH 2023, the health care industry conference

Bill would stop addiction treatment from triggering child abuse inquiry

hotspot

explore

knowledge

State Dept. review finds Biden bears some blame for Afghanistan failures

Bill would stop addiction treatment from triggering child abuse inquiry

Medical records are filled with copy

Phenylephrine and the overlooked value of the placebo effect

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Bill would stop addiction treatment from triggering child abuse inquiry

Hepatitis C has a cure — but many Americans still lack access to it

Solving academic medical centers' existential crisis

Duchenne breakthrough therapy leaves behind pioneering families

With measles on the rise, a personal story of a devastating disease

entertainment

Analysis of telehealth claims data suggest service duplication

Readers respond to H5N1 and livestock movements, and more

Bristol 'take

NVIDIA and Google execs on the future of AI and drug discovery

Anxious about a speech? A startup wants you to pop a minty cardiac drug

Chemotherapy drug shortage eases slightly but still widespread

knowledge

explore

focus

hotspot